India’s Glenmark Continues Push Into European Markets
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Indian drug maker Glenmark Pharmaceuticals will launch a division in Poland by acquiring seven generic pharmaceutical brands from Actavis, the Iceland-based generics major, and its Polish affiliate Biovena. The buy provides Glenmark an entry into the Polish market, estimated to be the largest in Central and East Europe